Follow the BioNexus Gene Lab Corp stock price and the full management transaction log of the company, a listed issuer based in United States. Shares are listed on the US market, under the authority of SEC (Form 4). Market capitalisation: €4.5m. The latest transaction was filed on 14 August 2026 (Attribution). Among the most active insiders: Bin Abdul Hamid Muhammad Azrul. The full history is free.
5
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Fundamental score
Ranked 28,759 of 29,062 companies
7.4
score / 100
Value
4
Quality
11
FCF yld-41%
Earn yld-66%
EV/EBITDA·
ROE-34%
Gross mgn15%
Net mgn-40%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.